IRIS Accounts Production v24.3.0.553 08681289 Board of Directors 1.6.23 31.5.24 31.5.24 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086812892023-05-31086812892024-05-31086812892023-06-012024-05-31086812892022-05-31086812892022-06-012023-05-31086812892023-05-3108681289ns15:EnglandWales2023-06-012024-05-3108681289ns14:PoundSterling2023-06-012024-05-3108681289ns10:Director12023-06-012024-05-3108681289ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3108681289ns10:SmallEntities2023-06-012024-05-3108681289ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3108681289ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3108681289ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3108681289ns10:FullAccounts2023-06-012024-05-3108681289ns10:Director22023-06-012024-05-3108681289ns10:Director32023-06-012024-05-3108681289ns10:Director42023-06-012024-05-3108681289ns10:RegisteredOffice2023-06-012024-05-3108681289ns5:CurrentFinancialInstruments2024-05-3108681289ns5:CurrentFinancialInstruments2023-05-3108681289ns5:Non-currentFinancialInstruments2024-05-3108681289ns5:Non-currentFinancialInstruments2023-05-3108681289ns5:ShareCapital2024-05-3108681289ns5:ShareCapital2023-05-3108681289ns5:FurtherSpecificReserve2ComponentTotalEquity2024-05-3108681289ns5:FurtherSpecificReserve2ComponentTotalEquity2023-05-3108681289ns5:RetainedEarningsAccumulatedLosses2024-05-3108681289ns5:RetainedEarningsAccumulatedLosses2023-05-3108681289ns5:FurnitureFittings2023-06-012024-05-3108681289ns5:ComputerEquipment2023-06-012024-05-3108681289ns5:FurnitureFittings2023-05-3108681289ns5:ComputerEquipment2023-05-3108681289ns5:FurnitureFittings2024-05-3108681289ns5:ComputerEquipment2024-05-3108681289ns5:FurnitureFittings2023-05-3108681289ns5:ComputerEquipment2023-05-3108681289ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3108681289ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3108681289ns5:Non-currentFinancialInstruments2023-06-012024-05-3108681289ns5:Secured2024-05-3108681289ns5:Secured2023-05-31
REGISTERED NUMBER: 08681289 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

HAYDOCK MEDICAL COMPANY LTD

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 5


HAYDOCK MEDICAL COMPANY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTORS: P A McDougall
C G Williams
M J Breach
T Swift





REGISTERED OFFICE: Woodside Healthcare Centre
Woodside Road
Haydock
St. Helens
Merseyside
WA11 0NA





REGISTERED NUMBER: 08681289 (England and Wales)





ACCOUNTANTS: C A Hunter Limited
Britannia Chambers
26 George Street
St Helens
Merseyside
WA10 1BZ

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

BALANCE SHEET
31 MAY 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 13,477 15,855
Investment property 5 5,541,584 5,541,584
5,555,061 5,557,439

CURRENT ASSETS
Debtors 6 355,009 301,427
Cash at bank 487 31,247
355,496 332,674
CREDITORS
Amounts falling due within one year 7 439,190 375,322
NET CURRENT LIABILITIES (83,694 ) (42,648 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,471,367

5,514,791

CREDITORS
Amounts falling due after more than one
year

8

(3,592,249

)

(3,733,793

)

PROVISIONS FOR LIABILITIES (483,916 ) (347,274 )
NET ASSETS 1,395,202 1,433,724

CAPITAL AND RESERVES
Called up share capital 100 100
Other reserves 10 881,394 881,394
Retained earnings 10 513,708 552,230
SHAREHOLDERS' FUNDS 1,395,202 1,433,724

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

BALANCE SHEET - continued
31 MAY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

BALANCE SHEET - continued
31 MAY 2024



The financial statements were approved by the Board of Directors and authorised for issue on 25 February 2025 and were signed on its behalf by:





C G Williams - Director


HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

Haydock Medical Company Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on cost
Computer equipment - 33% on cost

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 June 2023
and 31 May 2024 36,976 232 37,208
DEPRECIATION
At 1 June 2023 21,121 232 21,353
Charge for year 2,378 - 2,378
At 31 May 2024 23,499 232 23,731
NET BOOK VALUE
At 31 May 2024 13,477 - 13,477
At 31 May 2023 15,855 - 15,855

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 June 2023
and 31 May 2024 5,541,584
NET BOOK VALUE
At 31 May 2024 5,541,584
At 31 May 2023 5,541,584

Fair value at 31 May 2024 is represented by:
£   
Valuation in 2018 5,500,000
Valuation in 2019 41,584
5,541,584

If investment property had not been revalued it would have been included at the following historical cost:

31.5.24 31.5.23
£    £   
Cost 4,453,443 4,453,443
Aggregate depreciation (702,675 ) (601,692 )

Investment property was valued on an open market basis on 31 May 2024 by the directors. .

The directors consider that the investment property valuation of £5,541,584 is the fair value of the property at the 31st May 2024 Balance Sheet date.

HAYDOCK MEDICAL COMPANY LTD (REGISTERED NUMBER: 08681289)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade debtors 347,904 294,722
Other debtors 7,105 6,705
355,009 301,427

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Bank loans and overdrafts 134,117 138,436
Trade creditors 36,503 12,069
Taxation and social security 13,461 3,465
Other creditors 255,109 221,352
439,190 375,322

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.24 31.5.23
£    £   
Bank loans 3,345,689 3,472,513
Other creditors 246,560 261,280
3,592,249 3,733,793

The company received a lease premium in April 2017 of £368,000. The lease premium is being released to the profit and loss account over the 25 year life of the lease at the rate of £14,720 per annum..The total amount still to be released at the 31st May 2024 date is £261,280 (2023: £276,000) and this is included in Other creditors due in less than one year at £14,720 and more than one year at £246,560.

9. SECURED DEBTS

The following secured debts are included within creditors:

31.5.24 31.5.23
£    £   
Bank loans 3,479,806 3,610,949

The Bank Loan is secured by a first legal charge over the freehold land and buildings at Woodside Road, Haydock, St Helens , together with an unlimited debenture from Haydock Medical Company Limited.

The Bank Loan is also secured by guarantees provided by an individual director shareholder and a corporate shareholder in respect of all monies, up to £645,000 each.

10. RESERVES

Other reserves arise from the Investment Property fair value uplift of £1,088,141 at the 31st May 2024 date less an associated deferred tax provision of £206,747. The net reserve of £881,394 is non distributable.